Agenus makes senior regulatory and clinical appointments

Lexington, mass., sept. 12, 2022 (globe newswire) -- agenus (nasdaq: agen), an immuno-oncology company with an extensive pipeline of therapeutics designed to activate the immune response to cancers and infections, today announced the appointment of patricia carlos as chief regulatory, quality, and safety officer; todd yancey, md as global clinical development, medical affairs and commercial development advisor.
AGEN Ratings Summary
AGEN Quant Ranking